In this episode of "The Top Line," we talk with Dr Reanne Moore, an associate professor of psychiatry at the University of California San Diego, about the state of digital phenotyping. We also cover the vaccine patent lawsuits, the smallest insulin pump, and the rest of the week's headlines. 

To learn more about the topics in this episode:
Nominations for Fierce Biotech's 2023 Fierce 15 close Friday—three more days to submit
The Future of Biotech
ADC puts Zynlonta study on hold after 7 patient deaths, 5 other severe adverse events
Tandem crosses FDA finish line with nod for miniaturized insulin pump
Moderna mounts 2 new patent lawsuits against mRNA rivals Pfizer, BioNTech: report
Novartis retreats from TIGIT, handing $300M candidate back to BeiGene
Illumina receives record €432M fine from EU for false start on Grail deal

"The Top Line" is produced by senior podcast producer Teresa Carey. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.

In this episode of "The Top Line," we talk with Dr Reanne Moore, an associate professor of psychiatry at the University of California San Diego, about the state of digital phenotyping. We also cover the vaccine patent lawsuits, the smallest insulin pump, and the rest of the week's headlines. 
To learn more about the topics in this episode:
<ul>
<li><a href="https://www.fiercebiotech.com/biotech/its-time-fierce-biotechs-2023-fierce-15-nominations-are-now-open" data-cke-saved-href="https://www.fiercebiotech.com/biotech/its-time-fierce-biotechs-2023-fierce-15-nominations-are-now-open">Nominations for Fierce Biotech's 2023 Fierce 15 close Friday—three more days to submit</a></li>
<li><a href="https://www.fiercebiotechsummit.com/?utm_source=ppc&amp;utm_medium=google&amp;utm_campaign=fbs23&amp;gclid=CjwKCAjwwb6lBhBJEiwAbuVUSpPk1PPzUWIw-VBOgAvyXZSbJF2Qqryrb-VB45xiRroabTJFtHM9LhoCaWQQAvD_BwE" data-cke-saved-href="https://www.fiercebiotechsummit.com/?utm_source=ppc&amp;utm_medium=google&amp;utm_campaign=fbs23&amp;gclid=CjwKCAjwwb6lBhBJEiwAbuVUSpPk1PPzUWIw-VBOgAvyXZSbJF2Qqryrb-VB45xiRroabTJFtHM9LhoCaWQQAvD_BwE">The Future of Biotech</a></li>
<li><a href="https://www.fiercepharma.com/pharma/adc-therapeutics-puts-zynlonta-study-enrollment-pause-after-seven-patient-deaths-five-other?utm_medium=email&amp;utm_source=nl&amp;utm_campaign=LS-NL-FierceBiotech+Tracker&amp;oly_enc_id=8197B1373267B5C" data-cke-saved-href="https://www.fiercepharma.com/pharma/adc-therapeutics-puts-zynlonta-study-enrollment-pause-after-seven-patient-deaths-five-other?utm_medium=email&amp;utm_source=nl&amp;utm_campaign=LS-NL-FierceBiotech+Tracker&amp;oly_enc_id=8197B1373267B5C">ADC puts Zynlonta study on hold after 7 patient deaths, 5 other severe adverse events</a></li>
<li><a href="https://www.fiercebiotech.com/medtech/tandem-crosses-fda-finish-line-nod-miniaturized-insulin-pump?utm_medium=email&amp;utm_source=nl&amp;utm_campaign=LS-NL-FierceBiotech+Tracker&amp;oly_enc_id=8197B1373267B5C" data-cke-saved-href="https://www.fiercebiotech.com/medtech/tandem-crosses-fda-finish-line-nod-miniaturized-insulin-pump?utm_medium=email&amp;utm_source=nl&amp;utm_campaign=LS-NL-FierceBiotech+Tracker&amp;oly_enc_id=8197B1373267B5C">Tandem crosses FDA finish line with nod for miniaturized insulin pump</a></li>
<li><a href="https://www.fiercepharma.com/pharma/covid-vaccine-patent-war-heats-moderna-mounts-additional-infringement-lawsuits-against" data-cke-saved-href="https://www.fiercepharma.com/pharma/covid-vaccine-patent-war-heats-moderna-mounts-additional-infringement-lawsuits-against">Moderna mounts 2 new patent lawsuits against mRNA rivals Pfizer, BioNTech: report</a></li>
<li><a href="https://www.fiercebiotech.com/biotech/novartis-retreats-tigit-handing-300m-candidate-back-beigene" data-cke-saved-href="https://www.fiercebiotech.com/biotech/novartis-retreats-tigit-handing-300m-candidate-back-beigene">Novartis retreats from TIGIT, handing $300M candidate back to BeiGene</a></li>
<li><a href="https://www.fiercebiotech.com/medtech/illumina-receives-record-eu432m-fine-eu-false-start-grail-deal" data-cke-saved-href="https://www.fiercebiotech.com/medtech/illumina-receives-record-eu432m-fine-eu-false-start-grail-deal">Illumina receives record €432M fine from EU for false start on Grail deal</a></li>
</ul>
"The Top Line" is produced by senior podcast producer Teresa Carey. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning. 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.&nbsp;

The Top Line

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We’ll analyze the week’s biggest business news—from mergers and marketing to drug R&D and device development. Available every Friday morning.

 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We&rsquo;ll analyze the week&rsquo;s biggest business news&mdash;from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.
&nbsp;

Advertisement